ECT of major depressed patients in relation to biological and clinical variables: A brief overview

Neuropsychopharmacology

Volumn 28, Issue , 2003, Pages S21-S26

  Wahlund, Björn ^a   von Rosen, Dietrich ^a  

^a Biomathematics and Informatics ^*  (Sweden)

Author keywords

Connectivity; Depression; Ect; Eeg; Mechanism; Review

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROTROPHIC FACTOR;

CELL GROWTH; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HUMAN; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROIMAGING; NEUROMODULATION; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; ANIMAL; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; TREATMENT OUTCOME;

EID: 0043267729     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300135     Document Type: Article

References (52)

1. Abrams R (1992). Electroconvulsive Ther. Oxford University Press Inc.: New York.
2. Abrams R, Sukartz CM (1985b). ECT and Prolactin release: effects of stimulus parameters. Convuls Ther1: 115-119.
3. Aperia B, Thoren M, Wetterberg L (1985). Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness. Acta Psychiatr Scand72: 302-308.
4. Bergsholm P (1999). Electroconvulsive therapy. Handout. Depres-jenshandbekon. p. 115-144.
5. Devanand DP, Lisanby S, Lo ES, Fitzsimons L, Cooper TB, Halbreichu-Sackeim HA (1998). Effects of electroconvulsive therapy on plasma visopressin and oxytocin. Biol Psychiatry44: 610-616.
6. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA (2000). The hippocampus in-patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry57: 937-943.
7. Fink M, Abrams R (1998). EEG monitoring in ECT: a guide to treatment efficacy. Psychiatr Times XV: 1-8.
8. Fink M, Kahn RL (1957). Relation of EEG delta activity to behavioral response in electroshock: quantitative serial studies. Arch Neurol Psychiatry78: 516-525.
9. Fink M, Nemeroff CB (1989). A neuroendocrine view of ECT. Convuls Ther5: 296-304.
10. Florkowski CM, Crozier IG, Nightingale S, Evans MJ, Ellis MJ, Joyce P (1996). Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Clin Endocrinol (Oxf)44: 163-168.
11. Franke B, Bayatti N, Engele J (2000). Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro. Exp Neurol165: 125-135.
12. Gall C, Lauterborn J, Bundman M, Murray K, Isackson P (1991). Seizure and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res Suppl, 4: 225-245.
13. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W (1999). Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res844: 28-33.
14. Grant MM, Weiss JM (2001). Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biol Psychiatry49: 117-129.
15. Ishihara K, Sasa M (1999). Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. Jpn J Pharmacol80: 185-189.
16. Jiminez-Vasquez PA, Overstreet DH, Mathé AA (2000). Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatr Res34: 405-412.
17. Juckel G, Mendlin A, Jacobs BL (1999). Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology21: 391-398.
18. Kelly CB, Cooper SJ (1997). Plasma noradrenaline response to electroconvulsive therapy in depressive illness. Br J Psychiatry171: 182-186.
19. LeDoux J (1996). The Emotional Brain. The Mysterious Underpinnings of Emotional Life. Touchstone: New York.
20. Luber B, Nobler MS, Moeller JR, Katzman GP, Prudic J, Devanand DP (2000). Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. J ECT16: 229-243.
21. Maayan R, Yagorowski Y, Grupper D, Weiss M, Kaod MA, Weizman A (2000). Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to elctroconvul-sive therapy in depressed psychotic in-patients. Biol Psychiatry48: 693-701.
22. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000). Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry47: 1043-1049.
23. McGarvey KA, Zis AP, Brown EE, Nomikus GG, Fibiger HC (1993). ECS induced dopamine release: effects of electrode placement, anticonvubant treatment, and stimulus intensity. Biol Psychiatry34: 152-157.
24. Nobler MS, Luber B, Moeller JR, Katzman GP, Prudic J, Devanand DP (2000b). Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features I. Global analyses. J ECT16: 211-228.
25. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackheim HA (2001). Decreased regional brain metabolism after ECT. Am J Psychiatry158: 305-308.
26. Nobler MS, Roose SP, Prohovnik I, Moeller JR, Louie J, Van Heertum RL (2000a). Regional cerebral blood flow in mood disorders, v.: effects of antidepresant medication in late-life depresssion. Am J Geriatr Psychiatry8: 289-296.
27. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J (1993). EEG manifestations during ECT: effects of electrode placements and stimulus intensity. Biol Psychiatry34: 321-330.
28. Oosawa H, Fuji T, Kawastima K (1999). Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells. J Neurosci Res57: 381-387.
29. Pekary AE, Meyerhoff JL Sattin (2000). Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum. Brain Res884: 174-183.
30. Petrie RX, Reid IC, Stewart CA (2000). The -methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol Ther87: 11-25.
31. Plein H, Berk M (2000). Changes in the platelet intracellular calcium response to serotonin in-patients with major depression treated with electroconvulsive therapy: state or trait marker status. Int Clin Psychopharmacol15: 93-98.
32. Reid IC, Stewart CA (1997). Seizures, memory and synaptic plasticity. Seizure6: 351-359.
33. Reid IC, Stewart CA (2001). How antidepressants work: new perspectives on the pathophysiology of depressive disorder. Br J Psychiatry178: 299-303.
34. Robin A, Binnie CD, Copas JB (1985). Electrophysiological and hormonal responses to three types of electroconvulsive therapy. Br J Psychiatry147: 707-712.
35. Sackeim HA, Luber B, Katzman GP, Moeller JR, Prudic J, Devanand DP (1996). The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry53: 814-824.
36. Scott AIF, Milner JB, Shering PA (1989). Diminished TSH release after course of ECT: altered monoamine function or seizure activity?Psychoneuroendocrinology14: 425-431.
37. Scott AI, Whalley LJ, Legros JJ (1989). Treatment outcome, seizure duration, and the neurophysin respons to ECT. Biol Psychiatry25: 585-597.
38. Scott BW, Wojtowicz JM, Burnham WM (2000). Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol165: 231-236.
39. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM (1998). Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry172: 527-532.
40. Sperling MR, Pritchard PB, Engel Jr. J, Daniel C, Sagel J (1986). Prolactin in partial epilepsy: an indicator of limbic seizures. Ann Neurol20: 716-722.
41. Sperling MR, Wilson CL (1986). The effects of limbic and extralimbic electrical stimulation upon prolactin secretions in humans. Brain Res371: 293-297.
42. Stain-Malmgren R, Tham A, Aberg-Wistedt A (1998). Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression. J ECT14: 15-24.
43. Stewart C, Reid I (1993). Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Res620: 139-141.
44. Stewart CA, Reid IC (2000). Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl)148: 217-223.
45. Tortella FC, Long JB, Hong J-S, Holaday JW (1989). Modulation of endogenous opoid system by electroconvulsive shock. Convulsive Ther5: 261-273.
46. Uvnas-Moberg K, Bjorkstrand E, Hillegart V, Ahlenius S (1999). Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl)142: 95-101.
47. Werstiuk ES, Coote M, Griffith L, Shannon H, Steiner M (1996). Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients. Br J Psychiatry169: 758-765.
48. Whalley LJ, Eagles JM, Bowler GM, Bennie JG, Dick HR, McGuire RJ (1987). Selective effects of ECT on hypothalamic-pituitary activity. Psychol Med17: 319-328.
49. Whalley LJ, Rosie R, Dick H, Levy G, Watts AG, Sheward WJ (1982). Immediate increases in plasma prolactin and neurophy-sin but not other hormones after electroconvulsive therapy. Lancet2: 1064-1068.
50. Widerlow E, Ekman R, Jensen L, Borglund L, Nyman K (1989). Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment. J Neural Transm75: 101-109.
51. Yatham LN, Clark CC, Zis AP (2000). A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression. J ECT16: 171-176.
52. Yoshida K, Higuchi H, Kamata M, Yoshimoto M, Shimizu T, Hishikawa Y (1998). Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsy-chopharmacol Biol Psychiatry22: 435-444.